Finance & Investment
BioSapien raises $5.5M to build implantable chemo device targeting tumours from UAE base
UAE biotech startup BioSapien closed a $5.5M seed round to develop a bioelectronic implant that delivers chemotherapy directly to tumours, reducing systemic toxicity and potentially cutting hospital readmission costs.
4 Apr 2026 · 3 min read
